|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.000 (0.000%) | 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Turnover | 59,930 | -21.572% | 76,414 | 107,025 | 87,889 | 45,160 |
| Cost of Sales | (46,292) | -5.953% | (49,222) | (78,336) | (61,897) | (27,908) |
| Gross Profit | 13,638 | -49.846% | 27,192 | 28,689 | 25,992 | 17,252 |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (1,258) | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (4,000) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (42,294) | 7.392% | (39,383) | (8,709) | (5,331) | (34,340) | |
| Taxation | (203) | 14.689% | (177) | (405) | (1,228) | (1,435) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,310 | -- | (2,486) | (3,091) | (1,185) | (904) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (40,187) | -4.421% | (42,046) | (12,205) | (7,744) | (36,679) | |
| 2024/03 - Final HKD(K$) | %Chg (Compare to Final) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | 2020/03 HKD(K$) | |
| Net Finance Costs / (Income) | (593) | -- | 1,754 | (40) | (4,849) | (6,239) |
| Depreciation & Amortisation | 4,548 | 9.538% | 4,152 | 4,031 | 3,571 | 2,504 |
| Directors' Emoluments | 3,236 | -0.461% | 3,251 | 4,240 | 5,184 | 7,288 |
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Qualified |
Market Valuation Indicators
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| EPS (cts) | -8.450 | -14.300% | -9.860 | -2.960 | -1.900 | -8.900 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.013) | -- | (0.046) | 0.077 | (0.022) | (0.005) |
| NBV per share ($) | 0.109 | -- | 0.180 | 0.181 | 0.230 | 0.234235 |
| Remarks: | Real time quote last updated: 25/11/2024 07:39 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -40,187,000 |
| %Change | -4.421% |
| EPS / (LPS) | HKD -0.085 |
| NBV Per Share ($) | HKD 0.109 |